Follow The Filings

AIFF Firefly Neuroscience

Firefly Neuroscience earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by AIFF's executives, directors and 10% owners in the last 12 months, from their Form 4s

All AIFF insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Windsor Private Capital LP 10% owner, +7 joint filers
    Sale
    $290K 130,753 shares at $2.22 9.6% of stake
    Traded Oct 20–22 Filed Oct 22, 2025
  2. Windsor Private Capital LP 10% owner, +7 joint filers
    Sale
    $269K 102,675 shares at $2.62 7% of stake
    Traded Oct 15–17 Filed Oct 17, 2025
  3. Windsor Private Capital LP 10% owner, +7 joint filers
    Sale
    $457K 166,572 shares at $2.74 10% of stake
    Traded Oct 9–14 Filed Oct 14, 2025

Also filed in the last 12 months, not counted as buying or selling: 2 stock grants.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 5.02,9.01
10-Q FORM 10-Q
8-K 5.02,5.03,5.07,9.01
DEF 14A
424B3 PROSPECTUS
8-K 1.02,9.01
8-K 5.02,9.01
10-Q FORM 10-Q
8-K 1.01,3.02,9.01
8-K 1.01,3.02,9.01
10-K FORM 10-K
8-K 1.01,3.02,9.01
8-K 1.01,5.02,9.01
424B5 PROSPECTUS SUPPLEMENT
SCHEDULE 13D/A —
SCHEDULE 13D/A —
8-K 1.01,3.02,9.01
SCHEDULE 13D/A —
SCHEDULE 13G/A —
10-Q QUARTERLY REPORT
SCHEDULE 13D/A —
8-K 5.07,9.01
SCHEDULE 13D/A —
SCHEDULE 13D/A —
DEF 14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.